IRF1 Protein - Interferon Regulatory Factor 1

IRF1 Protein — Interferon Regulatory Factor 1

Introduction

IRF1 (Interferon Regulatory Factor 1) is a transcription factor that serves as a master regulator of interferon-stimulated genes and innate immune responses. While primarily studied in the context of antiviral immunity, IRF1 has emerged as a critical player in neuroinflammation and neurodegenerative diseases. In the brain, IRF1 is expressed in [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and [microglia](/entities/microglia), where it regulates inflammatory gene expression and cell survival pathways. This page provides comprehensive coverage of IRF1's structure, signaling, and role in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

IRF1 Protein — Interferon Regulatory Factor 1

Introduction

IRF1 (Interferon Regulatory Factor 1) is a transcription factor that serves as a master regulator of interferon-stimulated genes and innate immune responses. While primarily studied in the context of antiviral immunity, IRF1 has emerged as a critical player in neuroinflammation and neurodegenerative diseases. In the brain, IRF1 is expressed in [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and [microglia](/entities/microglia), where it regulates inflammatory gene expression and cell survival pathways. This page provides comprehensive coverage of IRF1's structure, signaling, and role in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">IRF1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Interferon Regulatory Factor 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[IRF1](/genes/irf1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P04855" target="_blank">P04855</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td>1IF1, 2IRF, 3ZW6</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>36 kDa (325 amino acids)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Nucleus</td></tr>
<tr><td><strong>Protein Family</strong></td><td>IRF family</td></tr>
<tr><td><strong>Expression</strong></td><td>Ubiquitous, high in brain, immune cells</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">186 edges</a></td>
</tr>
</table>
</div>

Overview

IRF1 is a transcription factor that binds to interferon-stimulated response elements (ISRE) and activates a broad array of interferon-stimulated genes (ISGs). Unlike IRF2 which acts as a repressor, IRF1 functions as a transcriptional activator. In the central nervous system, IRF1 plays complex roles in neuroinflammation, glial activation, and neuronal survival. Chronic or dysregulated IRF1 activation contributes to neuroinflammation, a hallmark of neurodegenerative diseases.

Structure

IRF1 contains distinct functional domains:

DNA-Binding Domain (N-terminal)

• DBD (residues 1-115): Highly conserved among IRF family
• Helix-turn-helix motif: Recognizes ISRE consensus sequence (AGTTTCNNT)
• Nuclear localization signal: Mediates nuclear import

Transcriptional Activation Domain (C-terminal)

• TAD (residues 140-280): Transactivates target genes
• Regulatory regions: Post-translational modification sites
• Interaction surfaces: Binds co-activators and other TFs

Signaling Pathway

Activation Mechanisms

IRF1 is activated by:

Signaling Cascade

Target Genes

IRF1 activates numerous genes:

• ISGs: OAS, MX, IFIT family
• MHC class I: Antigen presentation
• Chemokines: CXCL10, CCL5
• Inflammatory mediators: iNOS, COX-2
• Antiapoptotic: Some IRF1 targets are protective

Normal Physiological Functions

Antiviral Defense

• ISG induction: Broad antiviral gene program
• Direct antiviral effects: OAS, PKR, IFIT proteins
• Immune cell activation: Enhances antigen presentation

Immune Regulation

• T cell activation: Promotes Th1 differentiation
• NK cell function: Enhances cytotoxicity
• Macrophage activation: Increases phagocytosis

CNS Functions

• Microglial activation: Regulates innate immunity
• Astrocyte function: Modulates astrocyte responses
• Neuronal survival: Context-dependent effects

Role in Neurodegenerative Diseases

Alzheimer's Disease

IRF1 plays a complex role in [Alzheimer's disease](/diseases/alzheimers-disease):

Microglial Activation

• IRF1 highly activated in AD [microglia](/cell-types/microglia-neuroinflammation)
• Surrounds amyloid plaques
• Regulates pro-inflammatory gene expression

Neuroinflammation

• Chronic inflammation: Sustained IRF1 activation
• Cytokine production: IL-1β, TNF-α, IL-6
• Chemokine release: Attracts immune cells

Therapeutic Implications

• IRF1 as biomarker: Elevated in AD brain
• Modulation: Potential anti-inflammatory target

Parkinson's Disease

IRF1 contributes to [Parkinson's disease](/diseases/parkinsons-disease) pathogenesis:

• Dopaminergic neurons: IRF1 activated in substantia nigra
• Microglial activation: Contributes to neuroinflammation
• Oxidative stress: IRF1 regulates iNOS

Evidence

• Increased IRF1 in PD post-mortem brain
• Animal models show IRF1-mediated toxicity
• Genetic variants may modify PD risk

Amyotrophic Lateral Sclerosis

IRF1 is implicated in [ALS](/diseases/amyotrophic-lateral-sclerosis):

• Motor neuron disease: IRF1 in spinal cord
• Glial activation: Astrocyte and microglia
• Inflammatory cascade: Contributes to progression

Multiple Sclerosis

IRF1 plays a role in [multiple sclerosis](/diseases/multiple-sclerosis):

• Demyelination: Autoimmune attack
• T cell infiltration: Th1-mediated immunity
• Therapeutic targeting: IFN-β treatment

Therapeutic Implications

Targeting IRF1

• Anti-inflammatory strategies: Modulate IRF1 activation
• Microglial modulation: Reduce harmful inflammation
• Combination therapy: With disease-modifying treatments

Biomarker Potential

• Brain IRF1: Marker of neuroinflammation
• CSF biomarkers: Potential diagnostic use
• Therapeutic monitoring: Treatment response

Background

The study of Irf1 Protein Interferon Regulatory Factor 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

See Also

• [IRF1 Gene](/genes/irf1)
• [Interferon Signaling](/mechanisms/interferon-signaling)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Microglia](/entities/microglia)
• [Astrocytes](/entities/astrocytes)
• [Alzheimer's Disease](/diseases/alzheimers)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [JAK-STAT Signaling](/mechanisms/jak-stat-signaling)

External Links

• [<a href="https://www.uniprot.org/uniprot/P04855" target="_blank">UniProt: IRF1</a>](/mechanisms/dopaminergic-neuron-vulnerability)
• [<a href="https://www.ncbi.nlm.nih.gov/gene/3659" target="_blank">NCBI Gene: IRF1</a>](/mechanisms/dopaminergic-neuron-vulnerability)
• [<a href="https://www.phosphosite.org/proteinAction.action?id=9604" target="_blank">PhosphoSitePlus: IRF1</a>](/mechanisms/dopaminergic-neuron-vulnerability)